ArticleActa pharmacologica Sinica2026

MMP14-mediated proteolytic cleavage of LAMC2 domain III fragment drives osimertinib resistance in EGFR-mutant non-small cell lung cancer.

Cong-Hua Lu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.